MedPath

Feasibility of a Resistance Exercise and Dietary Protein Intervention in Elderly People in Practice (ProMuscle 65PK)

Not Applicable
Completed
Conditions
Sarcopenia
Interventions
Dietary Supplement: Dietary protein products
Other: Resistance exercise training
Registration Number
NCT02434289
Lead Sponsor
Wageningen University
Brief Summary

The purpose of this pilot study is to investigate the feasibility and potential impact of a combined resistance exercise and increased protein intake intervention in (frail) elderly, in a real-life setting.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
23
Inclusion Criteria
  • In home assisted (also informal care) elderly individuals, that experience loss of muscle strength
  • Able to understand and perform the study procedures
Exclusion Criteria
  • Type I or type II diabetes (fasted blood glucose level ≥7,0 mmol) or hypertension, unless well regulated by medication
  • Diagnosed cancer or Chronic Obstructive Pulmonary Disease (COPD)
  • Severe heart failure
  • Renal insufficiency (eGFR <60 mL/min/1.73 m2)
  • Newly placed hip/knee prosthesis (unless fully recovered), or recent surgery (stress on scar tissue)
  • Allergic or sensitive for milk proteins

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Resistance exercise and protein productsResistance exercise trainingPractice intervention trial including resistance exercise training and intake of dietary protein products in (frail) elderly, implemented by health care professionals.
Resistance exercise and protein productsDietary protein productsPractice intervention trial including resistance exercise training and intake of dietary protein products in (frail) elderly, implemented by health care professionals.
Primary Outcome Measures
NameTimeMethod
Feasibility of intervention implementationAfter 12 weeks

Feasibility includes acceptability, applicability, dose received and implementation integrity. Collected in both participants and implementing health care professionals

Secondary Outcome Measures
NameTimeMethod
Change in Quality of life, as measured by Short-Form 36 (SF-36)Baseline and 12 weeks
Change in Activities of Daily Living (ADL) functioning, as measured by ADL-questionnaireBaseline and 12 weeks
Change in physical performance, as measured by Short Physical performance Battery (SPPB), Timed Up-and-Go (TUG) and Six Minute Walking Test (6MWT)Baseline and 12 weeks
Change in skeletal muscle mass, as measured by Dual-energy X-ray Absorptiometry (DEXA)Baseline and 12 weeks
Change in muscle strength, as measured by a maximum strength testBaseline and 12 weeks

Trial Locations

Locations (1)

Zorggroep Noordwest-Veluwe, locatie Randmeer

🇳🇱

Harderwijk, Gelderland, Netherlands

© Copyright 2025. All Rights Reserved by MedPath